Los Altos Hills, CA, United States of America

Felix T Theeuwes

USPTO Granted Patents = 261 

 

 

Average Co-Inventor Count = 2.1

ph-index = 76

Forward Citations = 21,832(Granted Patents)


Inventors with similar research interests:


Location History:

  • Los Altos, CA (US) (1976 - 2008)
  • Los Altos Hills, CA (US) (1991 - 2023)

Company Filing History:


Years Active: 1976-2023

Loading Chart...
Loading Chart...
Loading Chart...
261 patents (USPTO):

Title: Felix Theeuwes: A Pioneer in Innovative Healthcare Solutions

Introduction:

Felix Theeuwes, a renowned inventor residing in Los Altos, CA, has earned immense recognition for his contributions in the field of medicine and drug delivery systems. With an impressive repertoire of 260 granted patents, Theeuwes is a visionary whose work has revolutionized the world of healthcare. This article explores his latest patents, career highlights, notable collaborations, and the influential companies he has been associated with.

Latest Patents:

Among Theeuwes' recent patents, two stand out for their potential to transform the treatment of various medical conditions. The first patent focuses on the innovative use of oxygenated cholesterol sulfates (OCS) in preventing and treating ischemia, organ dysfunction, and failure. By utilizing an oxygenated cholesterol sulfate called 5-cholesten-3,25-diol, 3-sulfate (25H-C3S), this method shows promise in addressing multiple organ dysfunction syndrome (MODS) and associated necrosis and apoptosis.

The second patent highlights the development of complexes comprising pharmaceutically active agents and functionalized polymers. These complexes leverage ionizable repeat units with ionizable side groups and/or end groups, forming non-covalent bonds with the pharmaceutically active agent. This innovation opens new doors for efficient drug delivery systems with enhanced therapeutic potential.

Career Highlights:

Throughout his illustrious career, Felix Theeuwes has significantly impacted the healthcare industry. Working with esteemed organizations such as Alza Corporation and Durect Corporation, Theeuwes has established himself as a pioneer in the development of advanced drug delivery systems. His patents have paved the way for improved patient care, emphasizing the importance of targeted treatments and efficient delivery mechanisms.

Collaborations:

Theeuwes' collaborations with accomplished colleagues have played a crucial role in his endeavors. Notably, he has worked closely with Patrick S Wong and Ronald P Haak, both esteemed professionals in the pharmaceutical and biotechnology sectors. These collaborations have fostered an environment of innovation, encouraging interdisciplinary approaches and inventive solutions in healthcare.

Conclusion:

Felix Theeuwes' remarkable journey as an inventor and innovator has propelled advancements in drug delivery systems and medical treatments. With his extensive patent portfolio and groundbreaking contributions, Theeuwes has left an indelible mark on the healthcare industry. His pioneering work continues to inspire future generations of inventors and serves as a testament to the power of innovation in improving the lives of patients worldwide.

Disclaimer: The information provided in this article is based on publicly available data and is for informational purposes only. The article does not endorse any specific products or companies mentioned.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…